More on TNGX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-5.7% Growth)
- Ratings (9.3 Score)

Upcoming Events

- Earnings (11/4/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tango Therapeutics, Inc (NQ:TNGX)
Delayed: 25.60 -0.05 (0.19%)
Prev. Close $25.65  
Open$25.21 
52 Wk High$ 
52 Wk Low$ 
Day High$25.70 
Day Low$24.75 
P/E N/A  
EPS$ 
Volume1,439,158 

Friends, Peers and Foes (?): ABBV, ONCY, TEVA, NUVL, PRAX (more...)

Aug 14, 2026 04:49 PM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Nextech Crossover I GP S.a r.l.
Aug 14, 2026 04:20 PM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
Aug 14, 2026 02:12 PM Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: GOLDMAN SACHS GROUP INC
Aug 14, 2026 11:05 AM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Woodline Partners LP
Aug 14, 2026 08:24 AM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
Aug 12, 2026 12:02 PM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2026 06:53 AM Tango Therapeutics Inc. (TNGX) PT Raised to $35 at Guggenheim
Aug 11, 2026 05:13 PM Form 8-K Tango Therapeutics, Inc. For: Aug 11
Aug 11, 2026 05:11 PM Form 424B5 Tango Therapeutics, Inc.
Aug 11, 2026 11:01 AM NeOnc Approaches a Major Biotech Inflection Point as tomorrow’s Brain-Cancer Data is set to Collide with a Tight Float
View All Articles

Entities mentioned with TNGX

View All Entities